Literature DB >> 14577656

Antioxidants in peripheral arterial disease.

F Violi1, L Loffredo, A Mancini, A Marcoccia.   

Abstract

Peripheral arterial disease (PAD) is an important manifestation of systemic atherosclerosis that is characterized by obstruction of the arteries in the lower limbs. Experimental and epidemiological studies suggested a key role for oxidative stress in initiation and progression of the atherosclerotic process. The results of these studies provided a good basis for interventional trials with antioxidants, particularly with vitamin E, but the findings were conflicting. In this paper we review the observational and interventional studies with antioxidants, and ask whether vitamins supplementation should or should be not be recommended for PAD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577656     DOI: 10.2174/1389450033490786

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  2 in total

1.  A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.

Authors:  Salvatore Santo Signorelli; Pasquale Fatuzzo; Francesco Rapisarda; Sergio Neri; Margherita Ferrante; Gea Oliveri Conti; Roberto Fallico; Luigi Di Pino; Giuseppe Pennisi; Gabriella Celotta; Anzaldi Massimiliano
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.